LIFELOC TECHNOLOGIES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
LIFELOC TECHNOLOGIES, INC. (LCTC) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 0 shares for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2023-11-08
- LIFELOC TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2023-09-30 was 0.00 shares.
- LIFELOC TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2021-12-31 was 90.00K shares.
- LIFELOC TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2021-09-30 was -90.00K shares, a 181.45% decline year-over-year.
- LIFELOC TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2021-06-30 was 0.00 shares.
- LIFELOC TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2021 was 110.50K shares, a 0.00% change from fiscal 2020.
- LIFELOC TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2020 was 110.50K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month |
|---|---|---|---|---|
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 0.00 shares 10-Q · filed 2023-11-08 | ||
| 2023-06-30 | 0.00 shares 10-Q · filed 2023-08-08 | |||
| 2021-12-31 | 90.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | 0.00 shares derived: sum of 2 quarters · filed 2022-11-10 | 0.00 shares derived: sum of 3 quarters · filed 2022-11-10 | 110.50K shares 10-K · filed 2022-03-03 |
| 2021-09-30 | -90.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -90.00K shares derived: sum of 2 quarters · filed 2022-11-10 | 20.50K shares 10-Q · filed 2022-11-10 | |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | 110.50K shares 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | 110.50K shares 10-Q · filed 2022-05-11 | |||
| 2020-12-31 | 110.50K shares 10-K · filed 2021-03-31 | |||
| 2020-09-30 | 110.50K shares 10-Q · filed 2021-10-29 | 110.50K shares derived: sum of 2 quarters · filed 2021-10-29 | 221.00K shares derived: sum of 3 quarters · filed 2021-10-29 | |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 110.50K shares 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | 110.50K shares 10-Q · filed 2021-05-12 |